DNA X financials
$4.19−3.68%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $16.2M | $0.00 | $0.00 | $15.0M | $15.0M | $11.5M | $16.8M | $13.4M | $27.6M |
| Gross profit | $0.00 | $0.00 | — | $1.8M | $0.00 | $0.00 | -$183.0K | $4.2M | $3.0M | $2.9M | $5.1M | $5.6M |
| Gross margin | — | — | — | 11.2% | — | — | −1.2% | 28.2% | 25.8% | 17.3% | 38.1% | 20.3% |
| Operating income | -$1.3M | -$3.6M | — | -$4.0M | -$1.5M | -$870.0K | -$22.1M | -$2.4M | -$6.5M | -$2.7M | -$1.3M | $688.0K |
| Net income | -$1.2M | $6.3M | — | -$4.8M | -$7.5M | $458.0K | -$21.6M | -$2.5M | -$6.6M | -$2.9M | -$1.4M | $527.0K |
| Net margin | — | — | — | −29.3% | — | — | −144.2% | −16.7% | −57.5% | −17.3% | −10.1% | 1.9% |
| Diluted EPS | $-0.92 | $5.01 | — | $-4.83 | $-14.15 | $1.41 | $-41.04 | $-9.32 | $-25.38 | $-11.70 | $-2.09 | $2.16 |
| EBITDA | -$1.1M | -$3.6M | $1.5M | -$3.0M | -$674.0K | $185.0K | -$21.3M | -$1.5M | -$2.4M | -$1.8M | -$299.0K | $755.0K |
| Operating cash flow | -$2.0M | -$3.5M | -$2.0M | -$7.0M | -$4.9M | -$9.6M | -$4.5M | -$417.0K | -$3.4M | -$168.0K | -$351.0K | -$304.0K |
| Free cash flow | -$2.0M | -$3.5M | -$2.0M | -$7.0M | -$4.9M | -$9.6M | -$4.5M | -$554.0K | -$3.4M | -$198.0K | -$363.0K | -$305.0K |
| Diluted shares | 1.4M | 1.3M | 1.1M | 1.0M | 0.5M | 0.3M | 0.5M | 0.3M | 0.3M | 0.2M | 0.6M | 0.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $900.0K | $1.2M | $1.3M | $2.1M | $2.0M | $2.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.4M | $1.1M | $5.1M | $5.1M | $2.9M | $2.8M |
| Total assets | $4.5M | $4.8M | $43.9M | $40.2M | $36.1M | $36.0M |
| Total liabilities | $5.7M | $4.9M | $50.6M | $40.9M | $37.4M | $37.0M |
| Shareholders' equity | -$1.2M | -$983.0K | -$6.7M | -$701.0K | -$1.3M | -$1.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology